Why Invest in Noxopharm

Noxopharm: Delivering Science. Transforming Lives.

A diverse biotechnology platform – optimising multiple drug discovery opportunities
A platform offering a revolutionary approach to therapeutics – to markets of substantial unmet medical need
Cancer & septic shock - two key focus areas of pharma M & A activity which combined are responsible for 40% (~20 million) of global deaths
Veyonda® has the potential to turn ‘COLD’ cancer tumours to ‘HOT’ – a highly sought outcome in the pharma industry
Lead drug candidate Veyonda® being developed as a potential treatment for a broad range of cancers
Run by a highly experienced management team in drug development and product commercialisation.